My Quote Request
6505-01-462-0075
20 Products
SB123
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505014620075
NSN
6505-01-462-0075
SB123
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505014620075
NSN
6505-01-462-0075
MFG
ALTHIN GROUP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS ACETATE, GLACIAL PER LITER AND 33.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM PER LITER AND 103.750 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: CENTRISOL BATH
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: MAGNESIUM PER LITER AND 137.000 MILLIEQUIVALENTS SODIUM PER LITER
Related Searches:
MK206404
METHYL SALICYLATE O
NSN, MFG P/N
6505014616278
NSN
6505-01-461-6278
MFG
VWR INTERNATIONAL INC DBA VWR SCIENTIFIC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYL SALICYLATE OIL OF WINTERGREEN BT 1 PINT
SPECIAL FEATURES: METHYL SALICYLATE (OIL OF WINTERGREEN); 1 PINT
Related Searches:
98-1458
POLYSORBATE 20 SOLU
NSN, MFG P/N
6505014616280
NSN
6505-01-461-6280
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: POLYOXYETHYLENESORBITAN MONOLAURATE (TWEEN 20); 100 ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYSORBATE 20 SOLUTION 100ML BT
Related Searches:
P1379
POLYSORBATE 20 SOLU
NSN, MFG P/N
6505014616280
NSN
6505-01-461-6280
MFG
SIGMA-ALDRICH CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: POLYOXYETHYLENESORBITAN MONOLAURATE (TWEEN 20); 100 ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYSORBATE 20 SOLUTION 100ML BT
Related Searches:
1A1322
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014616314
NSN
6505-01-461-6314
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: WITH NA 154 MEQ/L, CL 154 MEQ/L, APPROX 5.0 PH, 308 MOSMOL/L, GLASS SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00338-0044-02
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014616314
NSN
6505-01-461-6314
NDC00338-0044-02
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014616314
NSN
6505-01-461-6314
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: WITH NA 154 MEQ/L, CL 154 MEQ/L, APPROX 5.0 PH, 308 MOSMOL/L, GLASS SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
2D5633
MANNITOL INJECTION,USP
NSN, MFG P/N
6505014616347
NSN
6505-01-461-6347
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V MANNITOL ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: OSMITRAL IN WATER
TOTAL PRIMARY CONTAINER QUANTITY: 18
Related Searches:
NDC00338-0357-03
MANNITOL INJECTION,USP
NSN, MFG P/N
6505014616347
NSN
6505-01-461-6347
NDC00338-0357-03
MANNITOL INJECTION,USP
NSN, MFG P/N
6505014616347
NSN
6505-01-461-6347
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V MANNITOL ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: OSMITRAL IN WATER
TOTAL PRIMARY CONTAINER QUANTITY: 18
Related Searches:
DF18
ALCOHOL,USP
NSN, MFG P/N
6505014616569
NSN
6505-01-461-6569
MFG
SIEMENS HEALTHCARE DIAGNOSTICS INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 EACH
PRIMARY CONTAINER TYPE: CARTON
SPECIAL FEATURES: 12 MONTH EXPIRATION DATE
Related Searches:
5310-04
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505014619659
NSN
6505-01-461-9659
5310-04
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505014619659
NSN
6505-01-461-9659
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIEQUIVALENTS SODIUM ACTIVE INGREDIENT AND 20.000 MILLIEQUIVALENTS POTASSIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS CALCIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS MAGNESIUM ACTIVE INGREDIENT AND 30.000 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH 25 MQ ACETATE; ELECTROLYTE QUANTITIES ARE PER 25 ML; MUST BE DILUTED; PARTIAL FILL 25 ML IN A 30 ML GLASS VIAL; 25 PER PACKAGE, 100 PER CASE
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT
Related Searches:
HYPERLYTE R
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505014619659
NSN
6505-01-461-9659
HYPERLYTE R
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505014619659
NSN
6505-01-461-9659
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIEQUIVALENTS SODIUM ACTIVE INGREDIENT AND 20.000 MILLIEQUIVALENTS POTASSIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS CALCIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS MAGNESIUM ACTIVE INGREDIENT AND 30.000 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH 25 MQ ACETATE; ELECTROLYTE QUANTITIES ARE PER 25 ML; MUST BE DILUTED; PARTIAL FILL 25 ML IN A 30 ML GLASS VIAL; 25 PER PACKAGE, 100 PER CASE
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT
Related Searches:
NDC00703-5310-04
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505014619659
NSN
6505-01-461-9659
NDC00703-5310-04
ELECTROLYTE CONCENTRATE FOR INJECTION
NSN, MFG P/N
6505014619659
NSN
6505-01-461-9659
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIEQUIVALENTS SODIUM ACTIVE INGREDIENT AND 20.000 MILLIEQUIVALENTS POTASSIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS CALCIUM ACTIVE INGREDIENT AND 5.000 MILLIEQUIVALENTS MAGNESIUM ACTIVE INGREDIENT AND 30.000 MILLIEQUIVALENTS CHLORIDE
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH 25 MQ ACETATE; ELECTROLYTE QUANTITIES ARE PER 25 ML; MUST BE DILUTED; PARTIAL FILL 25 ML IN A 30 ML GLASS VIAL; 25 PER PACKAGE, 100 PER CASE
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT
Related Searches:
7828-08
RINGER'S IRRIGATION,LACTATED
NSN, MFG P/N
6505014619672
NSN
6505-01-461-9672
MFG
B BRAUN MEDICAL INC
Description
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
NDC00074-7828-08
RINGER'S IRRIGATION,LACTATED
NSN, MFG P/N
6505014619672
NSN
6505-01-461-9672
NDC00074-7828-08
RINGER'S IRRIGATION,LACTATED
NSN, MFG P/N
6505014619672
NSN
6505-01-461-9672
MFG
B BRAUN MEDICAL INC
Description
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 3000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
98-1421
L-TYROSINE
NSN, MFG P/N
6505014619898
NSN
6505-01-461-9898
MFG
FISHER SCIENTIFIC CO
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: L-TRYOSINE 5GM
Related Searches:
AC14064-0050
L-TYROSINE
NSN, MFG P/N
6505014619898
NSN
6505-01-461-9898
MFG
FISHER SCIENTIFIC CO
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: L-TRYOSINE 5GM
Related Searches:
98-2759
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505014619942
NSN
6505-01-461-9942
98-2759
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505014619942
NSN
6505-01-461-9942
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSP 150MG/ML 1ML VIAL
III SUPPLEMENTARY FEATURES: SUBSTITUTE FOR PREFERRED NSN OF 6505-01-529-5618
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 150 MG/ML; 1 ML; VIAL
Related Searches:
DEPO-PROVERA
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505014619942
NSN
6505-01-461-9942
DEPO-PROVERA
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505014619942
NSN
6505-01-461-9942
MFG
PHARMACIA & UPJOHN COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSP 150MG/ML 1ML VIAL
III SUPPLEMENTARY FEATURES: SUBSTITUTE FOR PREFERRED NSN OF 6505-01-529-5618
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 150 MG/ML; 1 ML; VIAL
Related Searches:
NDC00009-0746-30
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505014619942
NSN
6505-01-461-9942
NDC00009-0746-30
MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505014619942
NSN
6505-01-461-9942
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSP 150MG/ML 1ML VIAL
III SUPPLEMENTARY FEATURES: SUBSTITUTE FOR PREFERRED NSN OF 6505-01-529-5618
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 150 MG/ML; 1 ML; VIAL
Related Searches:
CENTRISOL
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505014620075
NSN
6505-01-462-0075
CENTRISOL
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505014620075
NSN
6505-01-462-0075
MFG
ALTHIN GROUP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS ACETATE, GLACIAL PER LITER AND 33.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM PER LITER AND 103.750 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: CENTRISOL BATH
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: MAGNESIUM PER LITER AND 137.000 MILLIEQUIVALENTS SODIUM PER LITER